Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.5400
Nov 17 • 1:01 PM ET Dollar change+0.0110 Percentage change(2.08%)
Today, 8:45 AMValion Bio completes 200-liter Entolimod production run with productivity 27% above historical data, supplying ongoing AFRRI study
Index
-
Market Cap
1.16M
Enterprise Value
24.10M
Income
-7.51M
Sales
0.48M
Book/sh
25.57
Cash/sh
0.98
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
52
IPO
Nov 11, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
2.42
P/B
0.02
P/C
0.55
P/FCF
-
EV/EBITDA
-
EV/Sales
50.22
Quick Ratio
0.86
Current Ratio
1.11
Debt/Eq
1.47
LT Debt/Eq
1.42
Option/Short
No / Yes
EPS (ttm)
-233.18
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
83.77% 59.16%
Sales past 3/5Y
- -
EPS Y/Y TTM
82.22%
Sales Y/Y TTM
-49.63%
EPS Q/Q
16.56%
Sales Q/Q
-100.00%
Insider Own
0.29%
Insider Trans
0.00%
Inst Own
4.50%
Inst Trans
5.27%
ROA
-156.00%
ROE
-178.18%
ROIC
-26.10%
Gross Margin
-58.51%
Oper. Margin
-1548.96%
Profit Margin
-1557.26%
SMA20
-15.33%
SMA50
-65.66%
SMA200
-95.93%
Trades
Shs Outstand
2.16M
Shs Float
2.15M
52W High
67.50 -99.20%
52W Low
0.47 14.53%
Volatility
9.25% 12.49%
ATR (14)
0.16
RSI (14)
24.17
Beta
1.87
Rel Volume
0.91
Avg Volume
1.76M
Volume
913,411
Perf Week
2.10%
Perf Month
-53.45%
Perf Quarter
-83.93%
Perf Half Y
-97.34%
Perf YTD
-98.51%
Perf Year
-98.56%
Perf 3Y
-99.93%
Perf 5Y
-100.00%
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
0.53
Price
0.54
Change %
2.08%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bolton SheryleDirectorApr 15 '26Buy1.0410,00010,40010,000Apr 20 04:02 PM
Valauri Christina RizopoulosDirectorApr 01 '26Buy0.9519,00018,00819,000Apr 02 09:49 AM
Valion Bio, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company was founded by Jennifer Ernst and John Claude on September 22, 2016 and is headquartered in San Antonio, TX.
Interim CEO & DirectorMr. J. Dean Zikria
PresidentMs. Lisa G. Wolf